NCT04343209 - Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP) | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

August 16, 2024

Study Completion Date

August 16, 2024

Conditions

Myocardial IschemiaCoronary DiseaseCoronary Artery DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Interventions

DIAGNOSTIC_TEST

Myocardial Perfusion Imaging Study

Evaluation of myocardial perfusion via PET imaging agent

DRUG

AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]

Cardiac PET imaging agent

Trial Locations (5)

15213

UPMC, Pittsburgh

19046

Adler Institute for Advanced Imaging, Jenkintown

33140

Doral Imaging Institute, LLC DBA CIRA Miami Beach, Miami Beach

33165

Doral Imaging Institute, LLC dba CIRA, Miami

79912

Molecular Imaging Technologies, El Paso